Reported Aug 3, 2016 · Terminated
Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA…
Teva North America
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Teva North America · 425 Privet Rd · Horsham, PA · 19044-1220
Is this the product you have?
- Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles
- Manufactured in Israel byTEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel
- Manufactured forTEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01
- Lot codes and dates
Lot #: 02D163Exp. 9/2017
- Amount recalled
- 14, 370 units
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
- PR
Why it was recalled
Failed Tablet/Capsule Specifications
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Teva North America recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.